SEC filings
GE HealthCare (GEHC)
Recent filings GE HealthCare made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001932393All filings on SEC.gov
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Taha Kass-Hout notified GE HealthCare Technologies Inc. on November 4, 2026 that he will resign as Chief Science and Technology Officer, with his last day set for December 31, 2026.
10-QQuarterly report
Quarterly report
GE HealthCare reported third-quarter 2026 revenue of $5.51 billion, up 7.2% as reported and 6.2% organically from a year earlier, with net income attributable to GE HealthCare of $615 million versus $446 million. …
8-KCurrent report
Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
GE HealthCare reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year over year, raised its full-year 2026 guidance, and said Jeannette Bankes will resign as President and CEO of Patient Care Solutions on November 15, 2026. …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
GE HealthCare Technologies Inc. appointed Pascal Desroches to its board of directors effective January 4, 2027, and named him to the Audit Committee and the Talent, Culture, and Compensation Committee effective the same date. …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
GE HealthCare Technologies Inc. appointed William K. Grogan, most recently executive vice president and chief financial officer of Xylem Inc., as its chief financial officer effective September 14, 2026, succeeding Jay Saccaro, who stepped…
8-KCurrent report
Regulation FD Disclosure
GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions, as part of a second-quarter 2026 leadership and organizational change, leaving the company with…
10-QQuarterly report
Quarterly report
GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions, leaving it with three segments — AIS, Pharmaceutical Diagnostics and Patient Care Solutions —…
8-KCurrent report
Results of Operations and Financial Condition
GE HealthCare reported second-quarter 2026 revenue of $5.3 billion, up 5.7% year over year with 3.5% organic growth, net income of $561 million and diluted EPS of $1.24, and reaffirmed its full-year 2026 guidance of 3.0%–4.0% organic…
8-KCurrent report
Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
GE HealthCare said Chief Financial Officer Jay Saccaro will step down effective August 14, 2026 to take a role outside the medical technology industry, and named Controller and Chief Accounting Officer George Newcomb as interim CFO while…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow GE HealthCare in Readster
Add GE HealthCare to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.